Morrow M - Search Results

1

Use of bilateral prophylactic nipple-sparing mastectomy in patients with high risk of breast cancer.

Valero MG, Moo TA, Muhsen S, Zabor EC, Stempel M, Pusic A, Gemignani ML, Morrow M, Sacchini V. Valero MG, et al. Among authors: morrow m. Br J Surg. 2020 Sep;107(10):1307-1312. doi: 10.1002/bjs.11616. Epub 2020 May 20. Br J Surg. 2020. PMID: 32432359 Free PMC article.

2

Patient selection for breast conservation therapy with magnification mammography.

Morrow M, Schmidt R, Hassett C. Morrow M, et al. Surgery. 1995 Oct;118(4):621-6. doi: 10.1016/s0039-6060(05)80027-3. Surgery. 1995. PMID: 7570314

3

Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.

Karam AK, Stempel M, Barakat RR, Morrow M, Gemignani ML. Karam AK, et al. Among authors: morrow m. Gynecol Oncol. 2009 Mar;112(3):490-5. doi: 10.1016/j.ygyno.2008.11.006. Epub 2008 Dec 20. Gynecol Oncol. 2009. PMID: 19101713

4

Prophylactic mastectomy and the timing of breast reconstruction.

Morrow M, Mehrara B. Morrow M, et al. Br J Surg. 2009 Jan;96(1):1-2. doi: 10.1002/bjs.6463. Br J Surg. 2009. PMID: 19109821 No abstract available.

5

Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodes.

Karam AK, Hsu M, Patil S, Stempel M, Traina TA, Ho AY, Cody HS, Port ER, Morrow M, Gemignani ML. Karam AK, et al. Among authors: morrow m. Ann Surg Oncol. 2009 Jul;16(7):1952-8. doi: 10.1245/s10434-009-0440-6. Epub 2009 Apr 18. Ann Surg Oncol. 2009. PMID: 19381724

6

Presenting features of breast cancer differ by molecular subtype.

Wiechmann L, Sampson M, Stempel M, Jacks LM, Patil SM, King T, Morrow M. Wiechmann L, et al. Among authors: morrow m. Ann Surg Oncol. 2009 Oct;16(10):2705-10. doi: 10.1245/s10434-009-0606-2. Epub 2009 Jul 11. Ann Surg Oncol. 2009. PMID: 19593632

7

Surgical management of the axilla: do intramammary nodes matter?

Pugliese MS, Stempel MM, Cody HS 3rd, Morrow M, Gemignani ML. Pugliese MS, et al. Among authors: morrow m. Am J Surg. 2009 Oct;198(4):532-7. doi: 10.1016/j.amjsurg.2009.06.007. Am J Surg. 2009. PMID: 19800463

8

Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer.

Pugliese MS, Karam AK, Hsu M, Stempel MM, Patil SM, Ho AY, Traina TA, Van Zee KJ, Cody HS 3rd, Morrow M, Gemignani ML. Pugliese MS, et al. Among authors: morrow m. Ann Surg Oncol. 2010 Apr;17(4):1063-8. doi: 10.1245/s10434-009-0834-5. Epub 2009 Dec 22. Ann Surg Oncol. 2010. PMID: 20033325

9

Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?

Port ER, Patil S, Stempel M, Morrow M, Cody HS 3rd. Port ER, et al. Among authors: morrow m. Cancer. 2010 Apr 15;116(8):1987-91. doi: 10.1002/cncr.24964. Cancer. 2010. PMID: 20151427 Free article.

10

A prospective evaluation of the durability of palliative interventions for patients with metastatic breast cancer.

Morrogh M, Miner TJ, Park A, Jenckes A, Gonen M, Seidman A, Morrow M, Jaques DP, King TA. Morrogh M, et al. Among authors: morrow m. Cancer. 2010 Jul 15;116(14):3338-47. doi: 10.1002/cncr.25034. Cancer. 2010. PMID: 20564060 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,264 results

Search Page

Filters